Skip NavigationSkip to Content

Intranasal Protollin (TM)/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection

  1. Author:
    Jones, T.
    Adamovicz, J. J.
    Cyr, S. L.
    Bolt, C. R.
    Bellerose, N.
    Pitt, L. M.
    Lowell, G. H.
    Burt, D. S.
  2. Author Address

    ID Biomed Corp Quebec, Montreal, PQ H7V 3S8, Canada. USA, Med Res Inst Infect Dis, Ft Detrick, Frederick, MD 21702 USA.;Jones, T, ID Biomed Corp Quebec, 525 Cartier Blvd W, Montreal, PQ H7V 3S8, Canada.;tjones@idbiomedical.com
    1. Year: 2006
    2. Date: Mar
  1. Journal: Vaccine
    1. 24
    2. 10
    3. Pages: 1625-1632
  2. Type of Article: Article
  3. ISSN: 0264-410X
  1. Abstract:

    FIN is a recombinant plague antigen comprising the capsular (F1) and virulence-associated (V) proteins. Given intramuscularly with Alhydrogel, it protects mice against challenge, but is less effective in non-human primates against high-dose aerosolized Yersinia pestis challenge, perhaps because it fails to induce respiratory immunity. Intranasal immunization of mice with F1-V formulated with a Proteosome-based adjuvant (Protollin (TM)), elicited high titers of specific IgA in lungs whereas intranasal F1-V alone or intramuscular Alhydrogel-adsorbed F1-V did not. The Protollin-adjuvanted F1-V vaccine also induced high serum titers of specific IgG, comparable to those induced by intramuscular Alhydrogel-adsorbed F1-V. Mice immunized intranasally with Protollin-F1-V were 100% protected against aerosol challenge with 170 LD50 of Y. pestis and 80% against 255 LD50. (c) 2005 Elsevier Ltd. All rights reserved.

    See More

External Sources

  1. DOI: 10.1016/j.vaccine.2005.09.052
  2. WOS: 000236259500018

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel